RNAZ
TransCode Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD5.04
-0.24 (-4.64%)
Rating:B-
Company Profile
CEO
Philippe Calais
IPO Date
2021-07-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$4.25
Prev. Close
$5.29
Day Low
$3.85
Day High
$5.22
52W Low
$3.85
52W High
$20.99
Market Cap
$0.00B
Volume
2.32M